SCHEMBL26310834

SCHEMBL26310834

Cc1ccccc1-c1cc(C2CCCC2)c(C)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.41
CYP2D6 P10635 6/20 0.41
CYP2C19 P33261 6/20 0.41
CYP3A4 P08684 5/20 0.41
CLK4 Q9HAZ1 4/20 0.41
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 2/20 0.41
ALOX15 P16050 1/20 0.41
S1PR1 P21453 1/20 0.39
S1PR5 Q9H228 1/20 0.39
MAPK1 P28482 3/20 0.38
TSHR P16473 2/20 0.38
IDO1 P14902 1/20 0.38
METAP2 P50579 1/20 0.38
CYP11B2 P19099 1/20 0.38
MAP4K1 Q92918 1/20 0.37
TP53 P04637 1/20 0.36
HIF1A Q16665 1/20 0.36
TGFBR1 P36897 1/20 0.36
GABRA1 P14867 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19373717 0.88 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C19CYP3A4CLK4
SCHEMBL22134627 0.85 S1PR1 (0.39) CYP1A2CYP2D6CYP2C19CYP3A4CLK4
SCHEMBL24104183 0.85 S1PR1 (0.41) CYP1A2CYP2D6CYP2C19CYP3A4CLK4
SCHEMBL19373741 0.85 CYP1A2 (0.39) CYP1A2CYP2D6CYP2C19CYP3A4CLK4
SCHEMBL18729486 0.83 LDHA (0.45) HSD17B10GABRA1LNPEPMAPTALOX5AP
SCHEMBL25984574 0.82 ADORA3 (0.37) HSD17B10LNPEPMAPTHPGDALOX5AP
SCHEMBL19373680 0.82 CYP1A2 (0.37) CYP1A2CYP2D6CYP2C19CYP3A4CLK4
SCHEMBL18729519 0.82 CYP1A2 (0.37) CYP1A2CYP2D6CYP2C19CYP3A4CLK4
SCHEMBL24104666 0.80 ADORA3 (0.40) S1PR1S1PR5GABRA1ALOX5APFEN1
SCHEMBL19373679 0.79 CYP1A2 (0.35) CYP1A2CYP2D6CYP2C19CYP3A4CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230354692-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-11-02 US disclosed
US-11744141-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11744141-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, LBR CYP1A2 605/4885CYP2D6 1022/4885CYP2C19 283/4885
US-20230354692-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LIFR, LBR, ZFR CYP1A2 1468/4885CYP2D6 965/4885CYP2C19 2370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.